nitroaspirin

T cell leukemia homeobox 2 ; Homo sapiens







5 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 18302761 NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols. 2008 Feb 26 1
2 17760507 Nitroaspirin (NCX-4016), an NO donor, is antiangiogenic through induction of loss of redox-dependent viability and cytoskeletal reorganization in endothelial cells. 2007 Nov 1
3 16144976 Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016). 2005 Dec 1
4 15063462 Chemiluminescence and LC-MS/MS analyses for the study of nitric oxide release and distribution following oral administration of nitroaspirin (NCX 4016) in healthy volunteers. 2004 Apr 16 1
5 12207011 NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function. 2002 Oct 1